This randomized controlled trial examined the effects of escitalopram, an SSRI, on sexual function in nondepressed midlife women experiencing vasomotor symptoms (VMS). Over an 8-week period, escitalopram did not significantly impact overall sexual function compared to placebo, though small reductions in lubrication (P=0.02) and a marginally nonsignificant decrease in orgasm
